An interrogation of the same Atlas database, to evaluate MMP-2 levels in seminoma compared with non-seminoma tumors, showed a significant higher level of MMP-2 in seminoma samples (Figure 5E), supporting the role of PTTG1 nuclear transcriptional activity in driving MMP-2 levels. Here, PTTG1 is linked to seminoma.